Nirvana Life Sciences Inc. (CSE:NIRV.X)
Canada · Delayed Price · Currency is CAD 0.0500
0.00 (0.00%)
At close: Sep 4, 2026
Nirvana Life Sciences Market Cap
Nirvana Life Sciences has a market cap or net worth of CAD 1.15 million as of September 18, 2026. Its market cap has increased by 179.57% in one year.
Market Cap
1.15M
Enterprise Value
1.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since March 17, 2022, Nirvana Life Sciences's market cap has decreased from 4.27M to 1.15M, a decrease of -73.15%. That is a compound annual growth rate of -25.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.15M | -33.33% |
| Dec 29, 2025 | 1.72M | -28.71% |
| Dec 27, 2024 | 2.41M | 150.00% |
| Dec 28, 2023 | 964.66K | -81.10% |
| Dec 19, 2022 | 5.10M | 19.58% |
| Mar 17, 2022 | 4.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Justera Health | 1.24M |
| American Salars Lithium | 1.23M |
| Adonis Minerals | 1.21M |
| Syntheia | 1.18M |
| Torrent Gold | 1.17M |
| Adastra Holdings | 1.12M |
| Vencanna Ventures | 1.11M |
| Biocure Technology | 1.11M |